n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Coagulation Disorders, Blood in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiser, B | 1 |
| Hauptmann, J | 1 |
| Weiss, A | 1 |
| Markwardt, F | 1 |
1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Pharmacological characterization of a new highly effective synthetic thrombin inhibitor.
Topics: Animals; Blood Coagulation Disorders; Dipeptides; Hypotension; Kinetics; Lethal Dose 50; Liver; Mice | 1985 |